Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Bafilomycin A1

ATPase inhibitor
 
BML-CM110-0100 100 µg 162.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-380-030

Macrolide antibiotic that acts as a potent and selective inhibitor of vacuolar-type H+-ATPase (V-type) (IC50=004-0.4nmol/mg). Valuable tool for distinguishing among different types of ATPases. Inhibitor of endosomal acidification.¨Blocks lysosomal cholesterol trafficking in macrophages. Blocks pH regulation in brain cells.

Product Specification

Formula:C35H58O9
 
MW:622.8
 
CAS:88899-55-2
 
Purity:≥95% (HPLC, TLC)
 
Appearance:White powder to colorless film.
 
Solubility:Soluble in 100% ethanol, methanol or DMSO.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 1 year after receipt when stored at -20°C. Stock solutions are stable for up to 3 months at -20°C.
 
Handling:Protect from light.
 
Technical Info/Product Notes:Typical concentrations for use in cell culture are 50-100nM.
Note: Product is not sterile.
 
BML-CM110 structure
Please mouse over
BML-CM110 structure

Product Literature References

Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo: M. Lehmann, et al.; Eur. Respir. J. 50, 1602367 (2017), Abstract; Full Text
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma: V.K. Emruli, et al.; BMC Cancer 16, 493 (2016), Application(s): Transient knock-down of V-ATPase, Abstract; Full Text
Neutrophil and Alveolar Macrophage-Mediated Innate Immune Control of Legionella pneumophila Lung Infection via TNF and ROS: P. Ziltener, et al.; PLoS One 12, e1005591 (2016), Application(s): Cell culture, Abstract; Full Text
Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition: D. Park, et al.; Sci. Rep. 6, 21772 (2016), Application(s): Cell culture, Abstract; Full Text
Pharmacological Inhibition of ULK1 Blocks mTOR-Dependent Autophagy: K. J. Petherick, et al.; J. Biol. Chem. 290, 11376 (2015), Application(s): Cell Culture, Abstract; Full Text
Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry: A.M. Schläfli, et al.; Eur. J. Histochem. 59, 137 (2015), Application(s): Cell Culture, Abstract; Full Text
Revealing the fate of cell surface human P-glycoprotein (ABCB1): The Lysosomal Degradation Pathway: K. Katayama, et al.; Biochim. Biophys. Acta 1853, 2361 (2015), Application(s): Cell Culture, Abstract;
The role of cytoplasmic-to-lysosomal pH gradient in hydrophobic weak base drug sequestration in lysosomes: B. Zhitomirsky, et al.; Cancer Cell Microenviron. 2, e807 (2015), Application(s): Cell Culture, Fluorescence Microscopy, Full Text
Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation: D. Brigger, et al.; Biochem. Biophys. Res. Commun. 438, 283 (2013), Application(s): Fluorescence Microscopy, PCR, WB, Abstract;
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling: S.M. Bernhard, et al.; Biochem. Pharmacol. 84, 1643 (2012), Application(s): WB, Cell Lysis, Abstract;
Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection: J.J. Shacka, et al.; Autophagy 2, 228 (2006), Review, Abstract;
Bafilomycin A1-sensitive pathway is required for the maturation of cystic fibrosis transmembrane conductance regulator: T. Okiyoneda, et al.; Biochim. Biophys. Acta 1763, 1017 (2006), Abstract;
Reduced capacitative calcium entry correlates with vesicle accumulation and apoptosis: S. Jaydev, et al.; J. Biol. Chem. 274, 8261 (1999), Abstract;
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases: S. Dröse & K. Altendorf; J. Exp. Biol. 200, 1 (1997), Abstract;
Inhibition of mitogen-induced DNA synthesis by bafilomycin A1 in Swiss 3T3 fibroblasts: A.J. Saurin, et al.; Biochem. J. 313, 65 (1996), Abstract;
Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases: J. Knops, et al.; J. Biol. Chem. 270, 2419 (1995), Abstract; Full Text
Inositol trisphosphate-dependent and -independent Ca2+ mobilization pathways at the vacuolar membrane of Candida albicans: C.M. Calvert & D. Sanders; J. Biol. Chem. 270, 7272 (1995), Abstract; Full Text
Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death: T. Nishihara, et al.; BBRC 212, 255 (1995), Abstract;
The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type beta-amyloid precursor protein: C. Haass, et al.; J. Biol. Chem. 270, 6186 (1995), Abstract; Full Text
Active vacuolar H+ATPase is required for both endocytic and exocytic processes during viral infection of BHK-21 cells: H. Palokangas, et al.; J. Biol. Chem. 269, 17577 (1994), Abstract; Full Text
Bafilomycin inhibits proton flow through the H+ channel of vacuolar proton pumps: B.P. Crider, et al.; J. Biol. Chem. 269, 17379 (1994), Abstract; Full Text
A depolarization-stimulated, bafilomycin-inhibitable H+ pump in hippocampal astrocytes: C.A. Pappas & B.R. Ransom; Glia 9, 280 (1993), Abstract;
Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, blocks lysosomal cholesterol trafficking in macrophages: T. Furuchi, et al.; J. Biol. Chem. 268, 27345 (1993), Abstract; Full Text
Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases: S. Drose, et al.; Biochemistry 32, 3902 (1993), Abstract;
Bafilomycin A1 inhibits the targeting of lysosomal acid hydrolases in cultured hepatocytes: K. Oda, et al.; BBRC 178, 369 (1991), Abstract;
Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells: T. Yoshimori, et al.; J. Biol. Chem. 266, 17707 (1991), Abstract; Full Text
Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption: K. Sundqui, et al.; BBRC 168, 309 (1990), Abstract;
Kinetic studies of chromaffin granule H+-ATPase and effects of bafilomycin A1: H. Hanada, et al.; BBRC 170, 873 (1990), Abstract;
The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase: T. Umata, et al.; J. Biol. Chem. 265, 21940 (1990), Abstract; Full Text
The evolution of H+-ATPases [see comments]: N. Nelson & L. Taiz; TIPS 14, 113 (1989), (Review), Abstract;
Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells: E.J. Bowman, et al.; PNAS 85, 7972 (1988), Abstract;
Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity: G. Werner, et al.; J. Antibiot. 37, 110 (1984), Abstract;

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,